1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Abbott Acquires Kalila Medical

M&A Deal Summary

Abbott Acquires Kalila Medical

On February 5, 2016, Abbott acquired medical products company Kalila Medical from Merieux Equity Partners

Acquisition Highlights
  • This is Abbott’s 15th transaction in the Medical Products sector.
  • This is Abbott’s 23rd transaction in the United States.
  • This is Abbott’s 11th transaction in California.

M&A Deal Summary
Date 2016-02-05
Target Kalila Medical
Sector Medical Products
Buyer(s) Abbott
Sellers(s) Merieux Equity Partners
Deal Type Add-on Acquisition

Target

Kalila Medical

Campbell, California, United States
Kalila Medical, Inc. is a medical device company developing next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders, including atrial fibrillation.

Search 205,819 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 42.0B USD (2024)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 30 of 35
Sector (Medical Products) 15 of 20
Type (Add-on Acquisition) 30 of 35
State (California) 11 of 14
Country (United States) 23 of 28
Year (2016) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-01 Alere

Waltham, Massachusetts, United States

Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere was founded in 1981 and is based in Waltham, Massachusetts.

Buy $5.8B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-28 St. Jude Medical

Saint Paul, Minnesota, United States

St. Jude Medical, Inc. is a medical device manufacturer dedicated to transforming the treatment of most expensive, epidemic diseases. St. Jude Medical five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management and cardiovascular. St. Jude Medical was formed in 1976 and is based in St. Paul, Minnesota.

Buy $25.0B

Seller(S) 1

SELLER

Merieux Equity Partners

Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2009
PE ASSETS 1.3B EUR
Size Large
Type Sector Focused
DESCRIPTION

Mérieux Développement SAS is a venture and growth capital investment firm associated with family holding company Institut Mérieux. The Firm focuses on the health and nutrition sectors and will consider opportunities throughout North America and Europe. Mérieux Développement SAS was established in 2009 and is headquartered in Lyon, France.

DEAL STATS #
Overall 2 of 5
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 1 of 2
State (California) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-15 Advencis Sarl

Mutzig, France

Advencis Sarl are an innovative company in instrumentation for the Life Sciences & Healthcare sectors. Company focus is on developing innovative and easy-to-use products for customers that deliver highly valued benefits to final users.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-21 Seqens

Ecully, France

Seqens is a global diversified chemicals Group that produces and distributes essential chemicals that are used in everyday products. Seqens offers a broad portfolio of active ingredients, pharmaceutical intermediates, and specialty ingredients, develops and industrializes the most demanding molecules, and relies on its ability to innovate, develop and implement the best available technologies. Seqens was founded in 2003 and is based in Ecully, France.

Buy -
Mergr

Product

Company

Legal